Optimal timing of radiotherapy following radical prostatectomy
Optimal timing of radiotherapy following radical prostatectomy
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours
Holistic management of patients with ALK-positive NSCLC
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial
Prostate cancer updates: Advances in precision medicine and PARP inhibitors
Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019
Role of molecular diagnostics in prostate cancer
Key developments in pancreatic cancer from ESMO 2019
Melanoma highlights from ESMO 2019
IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer
BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer
Comment: Pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breast cancer